Beijing, China

Chen Wang

USPTO Granted Patents = 65 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 60(Granted Patents)

DiyaCoin DiyaCoin 0.18 


Inventors with similar research interests:


Company Filing History:

goldMedal13 out of 633 
 
China Academy of Telecommunications Technology
 patents
silverMedal8 out of 8 
 
Eucure (beijing) Biopharma Co., Ltd.
 patents
bronzeMedal4 out of 33 
 
Biocytogen Pharmaceuticals (beijing) Co., Ltd.
 patents
44 out of 18,140 
 
Boe Technology Group Co., Ltd.
 patents
53 out of 703 
 
Datang Mobile Communications Equipment Co., Ltd.
 patents
63 out of 2,303 
 
Beijing Boe Optoelectronics Technology Co., Ltd.
 patents
73 out of 797 
 
Beijing Baidu Netcom Science and Technology Co., Ltd.
 patents
82 out of 79 
 
China National Petroleum Corporation
 patents
92 out of 19 
 
Cnpc Engineering Technology R&d Company Limited
 patents
102 out of 54,664 
 
Intel Corporation
 patents
112 out of 915 
 
Baidu Online Network Technology (beijing) Co., Ltd.
 patents
122 out of 61 
 
Beijing Kuangshi Technology Co., Ltd.
 patents
132 out of 2 
 
Beijing Tri-prime Genetic Engineering Co., Ltd
 patents
142 out of 2 
 
Beijing Bio-tech Development Co., Ltd.
 patents
152 out of 479 
 
Beijing Zitiao Network Technology Co., Ltd.
 patents
161 out of 5 
 
Beijing Kt Micro, Ltd.
 patents
171 out of 54,638 
 
Microsoft Technology Licensing, LLC
 patents
181 out of 12 
 
Beijing Mobike Technology Co., Ltd.
 patents
191 out of 27,108 
 
Huawei Technologies Co., Limited
 patents
201 out of 4,296 
 
Tsinghua University
 patents
211 out of 137 
 
Huawei Device (dongguan) Co., Ltd.
 patents
221 out of 164,108 
 
International Business Machines Corporation
 patents
231 out of 3 
 
Datang Mobile Communications Co., Ltd
 patents
241 out of 61 
 
China Agricultural University
 patents
251 out of 1 
 
Beijing Chengshi Wanglin Information Technology Co., Ltd.
 patent
261 out of 2 
 
Sironax Ltd.
 patents
271 out of 30,028 
 
Siemens Aktiengesellschaft
 patents
281 out of 98 
 
North China Electric Power University
 patents
291 out of 180 
 
Beijing Qihoo Technology Company Limited
 patents
301 out of 4 
 
Transport Planning and Research Institute Ministry of Transport
 patents
311 out of 1,470 
 
Hefei Xinsheng Optoelectronics Technology Co., Ltd.
 patents
321 out of 548 
 
Creative Technology Corporation
 patents
331 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
341 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2012-2025

where 'Filed Patents' based on already Granted Patents

65 patents (USPTO):

Title: Chen Wang: Innovator in Cancer Treatment

Introduction

Chen Wang, a prolific inventor based in Beijing, China, holds an impressive portfolio of 61 patents. His groundbreaking work primarily focuses on therapeutic interventions for cancer, positioning him at the forefront of biopharmaceutical innovation.

Latest Patents

Two of Wang's latest patents are making significant strides in cancer treatment methodologies. The first patent involves anti-PD-1 antibodies, which are crucial for targeting programmed cell death protein 1, a key regulator in immune response. This invention encompasses various antigen-binding fragments and outlines methods of treatment that could enhance patient outcomes in cancer therapies. The second patent centers around anti-CD40 antibodies, which target the TNF Receptor Superfamily Member 5. This patent also addresses the applications of these antibodies and their potential benefits in oncology.

Career Highlights

Throughout his career, Chen Wang has made substantial contributions to the field of biopharmaceuticals. He has collaborated with prominent institutions such as the China Academy of Telecommunications Technology and Eucure (Beijing) Biopharma Co., Ltd., where his innovations have driven significant advancements in cancer treatment technologies. His extensive research and development efforts have positioned these companies as leaders in the industry.

Collaborations

During his tenure, Wang has had the opportunity to collaborate with esteemed colleagues, including Yuelei Shen and Jingshu Xie. These partnerships have fostered a synergistic approach to research, enabling the exploration of novel therapeutic pathways in cancer treatment and expanding the frontiers of biomedical innovation.

Conclusion

Chen Wang stands out as a pioneering inventor whose contributions to the field of cancer treatment through his numerous patents are commendable. His dedication to advancing biopharmaceutical research not only reflects his commitment to improving patient care but also reinforces the importance of innovation in the healthcare sector. As Wang continues to explore new horizons in cancer therapy, the impact of his work is bound to resonate within both scientific communities and patient populations worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…